SINOPHARM: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
SINOPHARM: Overseas Regulatory Announcement
SINOPHARM: Overseas Regulatory Announcement
SINOPHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
SINOPHARM: Overseas Regulatory Announcement UNAUDITED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED 31 MARCH 2024
SINOPHARM: ANNOUNCEMENT PROPOSED CENTRALIZED REGISTRATION FOR THE ISSUE AMOUNT OF NON-FINANCIAL CORPORATE DEBT FINANCING INSTRUMENTS
SINOPHARM: ANNOUNCEMENT QUARTERLY FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2024
SINOPHARM: Overseas Regulatory Announcement
SINOPHARM: Overseas Regulatory Announcement
SINOPHARM: 2023 Sustainability Report
SINOPHARM: Annual Report 2023
SINOPHARM: Overseas Regulatory Announcement National Pharmaceutical Group Pharmaceutical Co., Ltd. First Quarter Report 2024
SINOPHARM: ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM (CNCM LTD) FOR THE FIRST QUARTER ENDED 31 MARCH 2024
SINOPHARM: Overseas Regulatory Announcement National Pharmaceutical Group YIJIH PHARMACEUTICAL CO., LTD. First Quarter Report 2024
SINOPHARM: ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE FIRST QUARTER ENDED 31 MARCH 2024
SINOPHARM: NOTICE OF BOARD MEETING
SINOPHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
SINOPHARM: Overseas Regulatory Announcement Guomedicine Group YICHI PHARMACEUTICAL CO., LTD. 2023 ANNUAL REPORT
SINOPHARM: ANNOUNCEMENT PRINCIPAL AUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE YEAR ENDED 31 DECEMBER 2023
SINOPHARM: PROPOSED DISTRIBUTION OF FINAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS
No Data